Genmab A/S
AXL-SPECIFIC ANTIBODIES FOR TREATMENT OF NON-SMALL CELL LUNG CANCER
Last updated:
Abstract:
The present invention relates to immunoconjugates anti-AXL antibodies and compositions for treatment of non-small cell lung cancer.
Status:
Application
Type:
Utility
Filling date:
26 Sep 2019
Issue date:
23 Dec 2021